Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
Status:
Recruiting
Trial end date:
2026-01-22
Target enrollment:
Participant gender:
Summary
Crohn's disease (CD) is a chronic inflammatory bowel disease. CD pathogenesis remains poorly
understood but involves an inappropriate immune response toward an unbalanced gut microbiota
in predisposed hosts.
The purpose of this study is to evaluate de clinical efficacy of the fecal microbiota
transplantation (FMT) as a maintenance treatment following anti-TNF agent withdrawal in CD's
patient.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
CRB-HUEP Institut National de la Santé Et de la Recherche Médicale, France